Ultragenyx Sells Portion of Future Crysvita Royalties to OMERS for $400 Million

Gibson, Dunn & Crutcher LLP has advised Ultragenyx Pharmaceutical Inc. Davies Ward Phillips & Vineberg LLP, Latham & Watkins LLP, and Sidley Austin LLP have advised…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here